KEYC - Global Molecular Diagnostics Partnering 2012-2018: Deal Trends,

Global Molecular Diagnostics Partnering 2012-2018: Deal Trends, Players, Financials and Forecasts -

Posted: Updated:


The "Global Molecular Diagnostics 2012-2018: Deal trends, players, financials and forecasts" report has been added to's offering.

The Global Molecular Diagnostics Partnering 2010-2018 report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest Molecular Diagnostics agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review Molecular Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Molecular Diagnostics partnering deals.

The report presents financial deal term values for Molecular Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

One of the key highlights of the report is that over 660 online deal records of actual Molecular Diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Molecular Diagnostics dealmaking

Chapter 3 - Leading Molecular Diagnostics deals

Chapter 4 - Most active Molecular Diagnostics dealmakers

Chapter 5 - Molecular Diagnostics contracts dealmaking directory

Chapter 6 - Molecular Diagnostics dealmaking by technology type

Chapter 7 - Partnering resource center

For more information about this report visit
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Molecular Diagnostics

Copyright Business Wire 2018

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and have questions or removal requests please contact